Leading lung cancer experts Dr Marina Garassino, Dr Luis Paz-Ares and Dr Martin Edelman share their perspectives on recent advances in the first-line treatment of ES-SCLC, the safety profiles of immunochemotherapies, how to manage side effects and more.
Watch now: https://touchoncology.com/cme/es-sclc-first-line-treatment/
-------------
This activity is funded by an independent medical education grant from AstraZeneca and is jointly provided by USF Health and touchIME.
Watch now: https://touchoncology.com/cme/es-sclc-first-line-treatment/
-------------
This activity is funded by an independent medical education grant from AstraZeneca and is jointly provided by USF Health and touchIME.
- Category
- Health
Be the first to comment